Acquired abnormal QT prolongation and torsade de pointes — clinical significance of genetic information from congenital long QT syndrome

2000 ◽  
pp. 99-111
Author(s):  
Wilhelm Haverkamp ◽  
G. Mönnig ◽  
L. Eckhardt ◽  
P. Kirchhof ◽  
H. Wedekind ◽  
...  
2006 ◽  
Vol 16 (1) ◽  
pp. 63-65 ◽  
Author(s):  
MAX SAUSSINE ◽  
ISLAM MASSAD ◽  
FRANCK RACZKA ◽  
JEAN-MARC DAVY ◽  
JEAN-MARC FRAPIER

1996 ◽  
Vol 28 (5) ◽  
pp. 1262-1268 ◽  
Author(s):  
Sami Viskin ◽  
Srinivasa R. Alla ◽  
Hal V. Barron ◽  
Karin Heller ◽  
Leslie Saxon ◽  
...  

2012 ◽  
Vol 23 (1) ◽  
pp. 141-145 ◽  
Author(s):  
E. Anne Greene ◽  
Charles I. Berul ◽  
Mary T. Donofrio

AbstractThis case describes the prenatal diagnosis and integrated peripartum management of a foetus with 2:1 atrioventricular block and torsade de pointes due to congenital long QT syndrome. The unique issues related to the detection of intrauterine conduction abnormalities and ventricular arrhythmias, along with the immediate postnatal care, have been described as an interesting teaching case with successful outcome.


2017 ◽  
Vol 22 (6) ◽  
pp. e12481 ◽  
Author(s):  
Nabil El-Sherif ◽  
Gioia Turitto ◽  
Mohamed Boutjdir

2012 ◽  
Vol 2012 ◽  
pp. 1-2 ◽  
Author(s):  
Mecnun Cetin ◽  
Munevver Yıldırımer ◽  
Serkan Özen ◽  
Sema Tanrıverdi ◽  
Senol Coskun

Long QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome after receiving clarithromycin for the treatment of atypical pneumonia.


Sign in / Sign up

Export Citation Format

Share Document